Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Receivables (2016 - 2017)

Historic Receivables for Northwest Biotherapeutics (NWBO) over the last 5 years, with Q4 2017 value amounting to $3.8 million.

  • Northwest Biotherapeutics' Receivables changed 0.0% to $3.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.8 million for FY2017, which is 0.0% changed from last year.
  • As of Q4 2017, Northwest Biotherapeutics' Receivables stood at $3.8 million, which was down 0.0% from $3.8 million recorded in Q2 2017.
  • In the past 5 years, Northwest Biotherapeutics' Receivables registered a high of $3.8 million during Q4 2016, and its lowest value of $3.8 million during Q4 2016.